rosiglitazone has been researched along with Colonic Neoplasms in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (68.75) | 29.6817 |
| 2010's | 5 (31.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aires, V; Brassart, B; Carlier, A; Delmas, D; Limagne, E; Mandard, S; Martiny, L; Scagliarini, A; Solary, E; Tarpin, M | 1 |
| Ehrmann, J; Hofmanová, J; Hyršlová Vaculová, A; Kozubík, A; Lauková, J; Moyer, MP; Nekvindová, J; Sova, P | 1 |
| Asp, ML; Belury, MA; Tian, M; Wendel, AA | 1 |
| Barrera, G; Cerbone, A; Daniela, B; Dianzani, MU; Ferretti, C; Giglioni, B; Menegatti, E; Minelli, R; Pettazzoni, P; Pizzimenti, S; Toaldo, C | 1 |
| Barrera, G; Cerbone, A; Ciamporcero, E; Dianzani, C; Dianzani, MU; Ferretti, C; Minelli, R; Pettazzoni, P; Pizzimenti, S; Roma, G; Toaldo, C; Ullio, C | 1 |
| Fujisawa, N; Ishimine, S; Kadowaki, T; Kawamori, T; Matsuhashi, N; Nakagama, H; Nakajima, A; Ochiai, M; Osawa, E; Sekihara, H; Wada, K | 1 |
| Burgermeister, E; Liscovitch, M; Tencer, L | 1 |
| Chintharlapalli, S; Safe, S; Samudio, I; Smith, R; Zhang, W | 1 |
| Allred, CD; Kilgore, MW | 1 |
| Brüne, B; Loitsch, S; Stein, J; Ulrich, S; von Knethen, A; Wächtershäuser, A | 1 |
| Bissonnette, RP; Cesario, RM; Lamph, WW; Stone, J; Yen, WC | 1 |
| Feng, Y; Hörling, J; Hu, X; Leng, Y; Liu, X; Sydow-Bäckman, M; Yang, YS; Yu, JH; Zhao, XF; Zierath, JR | 1 |
| Cao, JG; Dong, L; Liu, HQ; Qin, Y; Sun, L; Tang, XQ; Xia, H; Zhang, YQ | 1 |
| Barrera, G; Briatore, F; Cerbone, A; Dianzani, MU; Ferretti, C; Laurora, S; Pizzimenti, S; Toaldo, C | 1 |
| Allred, CD; Kilgore, MW; Southard, RC; Talbert, DR; Wang, X | 1 |
| Chan, KW; Dai, Y; Gu, Q; Lan, HY; Li, Z; Ma, J; Qiao, L; Wang, Y; Wong, BC; Wong, BL; Zou, B | 1 |
16 other study(ies) available for rosiglitazone and Colonic Neoplasms
| Article | Year |
|---|---|
A role for peroxisome proliferator-activated receptor gamma in resveratrol-induced colon cancer cell apoptosis.
Topics: Anilides; Apoptosis; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Humans; PPAR gamma; Resveratrol; Rosiglitazone; S Phase Cell Cycle Checkpoints; Stilbenes; Thiazolidinediones | 2014 |
Loss of PTEN Facilitates Rosiglitazone-Mediated Enhancement of Platinum(IV) Complex LA-12-Induced Apoptosis in Colon Cancer Cells.
Topics: Amantadine; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Drug Synergism; Energy Metabolism; G1 Phase Cell Cycle Checkpoints; HCT116 Cells; Humans; Membrane Potential, Mitochondrial; Mitochondria; Organoplatinum Compounds; PPAR gamma; PTEN Phosphohydrolase; RNA Interference; RNA, Small Interfering; Rosiglitazone; Thiazolidinediones; Tumor Suppressor Protein p53 | 2015 |
Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice.
Topics: Adenocarcinoma; Adiponectin; Animals; Autophagy; Blood Glucose; Cachexia; Colonic Neoplasms; Crosses, Genetic; Insulin; Insulin Resistance; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Muscle, Skeletal; Muscular Atrophy; Neoplasm Proteins; Proteasome Endopeptidase Complex; Proto-Oncogene Proteins c-akt; Random Allocation; Rosiglitazone; Thiazolidinediones; Weight Loss | 2010 |
PPARgamma ligands inhibit telomerase activity and hTERT expression through modulation of the Myc/Mad/Max network in colon cancer cells.
Topics: Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Blotting, Western; Caco-2 Cells; Colonic Neoplasms; DNA, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Ligands; PPAR gamma; Promoter Regions, Genetic; Prostaglandin D2; Protein Binding; Proto-Oncogene Proteins c-myc; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rosiglitazone; Telomerase; Thiazolidinediones | 2010 |
Rosiglitazone and AS601245 decrease cell adhesion and migration through modulation of specific gene expression in human colon cancer cells.
Topics: Acetonitriles; Benzothiazoles; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colonic Neoplasms; Fibrinogen; Gene Expression; Humans; Oligonucleotide Array Sequence Analysis; Real-Time Polymerase Chain Reaction; Rosiglitazone; Thiazolidinediones | 2012 |
Peroxisome proliferator-activated receptor gamma ligands suppress colon carcinogenesis induced by azoxymethane in mice.
Topics: Animals; Antineoplastic Agents; Azoxymethane; Carcinogens; Chromans; Colon; Colonic Neoplasms; Female; Immunohistochemistry; Ligands; Mice; Mice, Inbred BALB C; Pioglitazone; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone | 2003 |
Peroxisome proliferator-activated receptor-gamma upregulates caveolin-1 and caveolin-2 expression in human carcinoma cells.
Topics: Adenocarcinoma; Antigens, Differentiation; Antigens, Neoplasm; Breast Neoplasms; Caveolin 1; Caveolin 2; Caveolins; Cell Differentiation; Cell Line; Chromans; Colonic Neoplasms; Dimerization; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Genes, Dominant; Humans; Kidney; Ligands; Macromolecular Substances; Membrane Microdomains; Neoplasm Proteins; Phenotype; Phenylacetates; Prostaglandin D2; Protein Structure, Tertiary; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; RNA, Neoplasm; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Transcription, Genetic; Troglitazone; Tumor Cells, Cultured | 2003 |
1,1-Bis(3'-indolyl)-1-(p-substitutedphenyl)methanes induce peroxisome proliferator-activated receptor gamma-mediated growth inhibition, transactivation, and differentiation markers in colon cancer cells.
Topics: Apoptosis; Biomarkers, Tumor; Cell Cycle Proteins; Cell Differentiation; Cell Division; Cell Line, Tumor; Colonic Neoplasms; Humans; Indoles; Methane; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazolidinediones; Transcription Factors; Transcriptional Activation | 2004 |
Selective activation of PPARgamma in breast, colon, and lung cancer cell lines.
Topics: Alitretinoin; Anilides; Breast Neoplasms; Caco-2 Cells; Cell Line, Tumor; Colonic Neoplasms; Female; Gene Expression Regulation, Neoplastic; Genes, Reporter; HT29 Cells; Humans; Ligands; Lung Neoplasms; PPAR gamma; Prostaglandin D2; Retinoid X Receptor alpha; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Transfection; Tretinoin | 2005 |
Activation of PPARgamma is not involved in butyrate-induced epithelial cell differentiation.
Topics: Alkaline Phosphatase; Apoptosis; Butyrates; Caco-2 Cells; Cell Cycle Proteins; Cell Differentiation; Cell Proliferation; Colonic Neoplasms; Epithelial Cells; Humans; PPAR gamma; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones | 2005 |
Differentiation and growth inhibition mediated via the RXR:PPARgamma heterodimer in colon cancer.
Topics: Animals; Anticarcinogenic Agents; Bexarotene; Cell Differentiation; Cell Proliferation; Colonic Neoplasms; Cyclooxygenase 2; Fibrinolytic Agents; Humans; Male; Membrane Proteins; Mice; Mice, Nude; PPAR gamma; Prostaglandin D2; Retinoid X Receptors; Rosiglitazone; Tetrahydronaphthalenes; Thiazolidinediones; Transplantation, Heterologous; Tumor Cells, Cultured | 2006 |
Effect of a novel non-thiazolidinedione peroxisome proliferator-activated receptor alpha/gamma agonist on glucose uptake.
Topics: 3T3 Cells; Adenocarcinoma; Animals; Biological Transport; Cell Line, Tumor; Colonic Neoplasms; Coumarins; Genes, Reporter; Glucose; Humans; Mice; Muscle, Skeletal; Oxazoles; PPAR alpha; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2007 |
Rosiglitazone enhances fluorouracil-induced apoptosis of HT-29 cells by activating peroxisome proliferator-activated receptor gamma.
Topics: Anilides; Antimetabolites, Antineoplastic; Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Fluorouracil; Gene Expression Regulation; Humans; Hypoglycemic Agents; PPAR gamma; Proto-Oncogene Proteins c-bcl-2; Rosiglitazone; Thiazolidinediones | 2007 |
4-Hydroxynonenal and PPARgamma ligands affect proliferation, differentiation, and apoptosis in colon cancer cells.
Topics: Aldehydes; Apoptosis; bcl-2-Associated X Protein; Caco-2 Cells; Cell Differentiation; Cell Proliferation; Colonic Neoplasms; Cross-Linking Reagents; Cysteine Proteinase Inhibitors; Drug Synergism; Gene Expression; Humans; Ligands; PPAR gamma; Prostaglandin D2; Rosiglitazone; Thiazolidinediones | 2007 |
PPARgamma1 as a molecular target of eicosapentaenoic acid in human colon cancer (HT-29) cells.
Topics: Anilides; Cell Proliferation; Colonic Neoplasms; Eicosapentaenoic Acid; Gene Expression Regulation; HT29 Cells; Humans; Male; PPAR gamma; Prostatic Neoplasms; Protein Binding; Response Elements; Rosiglitazone; Thiazolidinediones | 2008 |
Loss of XIAP sensitizes rosiglitazone-induced growth inhibition of colon cancer in vivo.
Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Cell Division; Cell Line, Tumor; Colonic Neoplasms; Down-Regulation; Humans; In Situ Nick-End Labeling; PPAR gamma; Rosiglitazone; Thiazolidinediones; X-Linked Inhibitor of Apoptosis Protein | 2008 |